Answers are grounded in this paper and cite their sources.
Review reveals IVD regulatory frameworks impact market access in diverse regions, suggesting compliance is crucial for safety.
In-vitro diagnostics [IVDs] play a critical role in modern healthcare by enabling early disease detection, patient monitoring, and informed treatment decisions. These medical devices are defined and classified based on a risk-based approach, which impacts their entire lifecycle, from development to market access. The global IVD market is growing rapidly, driven by technological advancements and increasing healthcare demands. IVDs are subject to stringent regulations to ensure their safety and effectiveness, with frameworks varying by region. Key guidelines are provided by organizations such as the WHO and regulatory bodies in the US, EU, Japan, Australia, and India. These standards address pre-submission processes, registration requirements, and ongoing compliance to facilitate market entry and maintain patient safety. Market trends reveal a surge in the diversity of IVD products, reflecting their broad applications and technological innovation. From traditional laboratory tests to cutting-edge molecular diagnostics, IVDs cater to a wide range of healthcare needs. However, the integration of IVDs with combination products poses regulatory challenges, requiring careful navigation to ensure compliance. By striking a balance between innovation and regulatory requirements, IVDs continue to transform the healthcare landscape. This review provides stakeholders with a comprehensive understanding of IVD regulation, development, and market dynamics. With a focus on aligning with evolving healthcare priorities and safety standards, IVDs remain pivotal in advancing global health outcomes.
No takes yet. Share an insight, caveat, or question.
S. et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: